Patents Examined by Michael P Cohen
  • Patent number: 10314778
    Abstract: The present invention relates to an anhydrous composition comprising: 1) at least particles comprising a core containing at least one beneficial agent and an envelope surrounding the core; said envelope comprising at least one hydrophobically modified polysaccharide and at least one water-soluble carbohydrate and/or water-soluble polyol; said particles simultaneously having a poured powder density ranging from 300.0 g/l to 600.0 g/l and an absolute density of greater than 1.0; and 2) an oily phase. The invention additionally relates to a cosmetic process for caring for and/or for making up a keratin material, which consists in applying to the surface of said human keratin material a consumer product comprising a composition as defined previously.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: June 11, 2019
    Assignee: L'OREAL
    Inventors: Gérard Malle, Tiina Luukas, Isabelle Bara
  • Patent number: 10301275
    Abstract: Sweet taste modulators for enhancing sweetness of an oral consumer product having a sweetener are described. The sweet taste modulators include 5-ethoxymethyl-2-furaldehyde, 2,3-dihydroxybenzoic acid, 2,4-dihydroxybenzoic acid, 2,5-dihydroxybenzoic acid, 2,6-dihydroxybenzoic acid, 3,4-dihydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 2,3,4-trihydroxybenzoic acid, 2,4,6-trihydroxybenzoic acid and 3,4,5-trihydroxybenzoic acid, syringic aldehyde, sinapic aldehyde, ester of 5-hydroxymethylfurfural and vanillic acid, 4-hydrozybenzaldehyde, and 5-methoxymethylfurfural. A method of making 5-ethoxymethyl-2-furaldehyde and a method of making an oral consumer product are also described.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: May 28, 2019
    Assignee: Altria Client Services LLC
    Inventors: Andrea Froschmeier, Thomas Hofmann, Christian Schuh
  • Patent number: 10294193
    Abstract: The present invention addresses the problem of providing a novel compound capable of imparting a highly appealing floral and verdant scent, and a flavor composition and/or fragrance composition containing the same. This compound is a racemic or optically active compound represented by general formula (1). In formula (1), the solid and dotted double line indicates a double bond or a single bond, the definition of Y is the same as described in the specification, and * represents an asymmetric carbon atom.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: May 21, 2019
    Assignee: TAKASAGO INTERNATIONAL CORPORATION
    Inventors: Kenichiro Adachi, Hiroyuki Matsuda
  • Patent number: 10292937
    Abstract: Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) include dosage forms that deliver a therapeutic amount of active drug in a delayed and controlled release formulation. The dosage form can be administered at night and drug release is delayed for from 5 to 7 hours or longer, followed by an ascending release rate. When administered at night the composition provides early morning improvement in symptoms of ADHD and sustained improvement over a period of at least 12 hours.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: May 21, 2019
    Assignee: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
    Inventors: David Lickrish, Feng Zhang
  • Patent number: 10265277
    Abstract: Embodiments of the present invention relate to the use of a therapeutically-effective amount of Olivetol to reduce, eliminate, inhibit or alleviate the psychoactive effects of THC in users of Cannabis. Further embodiments of the present invention relate to a softgel, tablet or capsule of Olivetol in combination with an edible oil.
    Type: Grant
    Filed: April 18, 2018
    Date of Patent: April 23, 2019
    Assignee: UNDOO, LLC
    Inventor: James J. Carberry
  • Patent number: 10264788
    Abstract: A nonwoven wipe comprises an antiseptic solution comprising a bis-(dihydropyridinyl)-decane derivative, a first fiber having a denier of about 1.5 to about 2.0, and a second fiber having a denier of about 3.0 to 3.5. About 30 wt % to 70 wt % of the total weight of the nonwoven wipe is the first fiber and about 30 wt % to 70 wt % of the total weight of the nonwoven wipe is the second fiber. The bis-(dihydropyridinyl)-decane may be octenidine dihydrochloride.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: April 23, 2019
    Assignee: CAREFUSION 2200, INC.
    Inventors: Ramarao V. Gundlapalli, Hong Shen, Kenneth Bruce Thurmond, II, Christoper Varga
  • Patent number: 10265257
    Abstract: An aqueous shear-thinning personal care composition comprising: (a) at least 3 wt % of a sulfonate compound of general formula where R1 represents a C8-22 alkyl group alkyl group; R2 represents a C1-4 alkyl group; each of R3, R4 and R5 independently represents a hydrogen atom or a C1-4 alkyl group; and M+ represents a sodium or potassium cation; (b) at least 3 wt % of an amphoteric or zwitterionic surfactant; (c) at least 10 wt % of water; and (d) at least 0.5 wt % of an additional component in the form of particles or droplets suspended in the composition. The composition is stable in an aqueous environment and can be formulated with a wide range of additional components.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: April 23, 2019
    Assignee: Innospec Limited
    Inventor: Phillip Cotrell
  • Patent number: 10251900
    Abstract: Provided herein are methods for treating a pulmonary infection in a patient in need thereof, for example, a nontuberculous mycobacterial pulmonary infection for at least one treatment cycle. The method comprises administering to the lungs of the patient a pharmaceutical composition comprising a liposomal complexed aminoglycoside comprising a lipid component comprising electrically neutral lipids and an aminoglycoside. Administration comprises aerosolizing the pharmaceutical composition to provide an aerosolized pharmaceutical composition comprising a mixture of free aminoglycoside and liposomal complexed aminoglycoside, and administering the aerosolized pharmaceutical composition via a nebulizer to the lungs of the patient. The methods provided herein result in a change from baseline on the semi-quantitative scale for mycobacterial culture for a treated patient, and/or NTM culture conversion to negative during or after the administration period.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: April 9, 2019
    Assignee: INSMED INCORPORATED
    Inventors: Gina Eagle, Renu Gupta
  • Patent number: 10245222
    Abstract: Disclosed herein are dentifrices comprising a zinc amino acid halide, which provide a precipitate of zinc oxide upon use with dilution with water and/or saliva. Methods of making and using the dentifrices are also provided.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: April 2, 2019
    Assignee: Colgate-Palmolive Company
    Inventors: Long Pan, Shaotang Yuan, Shira Pilch, James Masters, Zhiqiang Liu, Vyoma Patel
  • Patent number: 10226447
    Abstract: An oral melatonin pharmaceutical dosage form that contains a sustained release dose of melatonin includes melatonin and an acid dispersed in a hydrogel-forming polymer matrix that combine after ingestion to form an acidic hydrogel containing the melatonin. The dosage form is effective to release melatonin therefrom for at least six hours after oral ingestion.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: March 12, 2019
    Assignee: Physician's Seal, LLC
    Inventors: Syed M. Shah, Daniel Hassan
  • Patent number: 10206858
    Abstract: Aluminum chlorohydrate salts having an amount of Peak 1 material relative based on a total of Peaks 3, 4, and 5 of at least 20% as measured by size exclusion chromatography, together with water treatment compositions, antiperspirant compositions, and oral care compositions, comprising the same, and methods for making and using the same.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: February 19, 2019
    Assignee: Colgate-Palmolive Company
    Inventors: Viktor Dubovoy, Long Pan
  • Patent number: 10201570
    Abstract: The present invention relates to the use of halogen compounds, including iodide, and chalcogenide compounds, including iodide, sulfide and selenide, to treat and prevent diseases and injuries. The present invention further relates to compositions comprising a halogen compound and/or a chalcogenide compound, including pharmaceutical compositions, as well as methods of manufacturing such compounds and administering such compositions to subjects in need thereof.
    Type: Grant
    Filed: February 10, 2015
    Date of Patent: February 12, 2019
    Assignee: Fred Hutchinson Cancer Research Center
    Inventors: Mark B. Roth, Michael L. Morrison, Akiko Iwata
  • Patent number: 10195125
    Abstract: The invention provides a zinc-lysine complex having the formula [Zn(C6H14N2O2)2Cl]+Cl? having antibacterial and antiperspirant properties, together with personal care compositions comprising the complex, and methods of making and using these complexes and compositions.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: February 5, 2019
    Assignee: Colgate-Palmolive Company
    Inventors: Long Pan, Jairajh Mattai, Shaotang Yuan, James Masters
  • Patent number: 10188614
    Abstract: The present invention relates to active substances in particulate form, to methods for preparing them and to their uses. The present invention provides particulate powders, such as might be of use for delivery using a dry powder inhaler (DPI) or similar delivery device, having properties which may be beneficial to the DPI delivery process.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: January 29, 2019
    Assignee: Nektar Therapeutics
    Inventors: Peter York, Boris Yu Shekunov, Mahboob Ur Rehman, Jane Catherine Feeley
  • Patent number: 10188112
    Abstract: Provided is a personal cleansing composition for application to the skin which comprises a zinc X halide present in an amount to provide at least 0.36 weight % of the composition of zinc, and a surfactant, wherein X is an amino acid or trimethylglycine. Methods of making and using the compositions are also provided. The zinc X halide is can be used to deliver zinc salts to reduce or prevent sunburn, kill bacteria, or reduce perspiration.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: January 29, 2019
    Assignee: Colgate-Palmolive Company
    Inventors: Eugene Hardy, Long Pan, Shiri Nawrocki, Evangelia Arvanitidou, Laurence D. Du-Thumm
  • Patent number: 10182995
    Abstract: Therapeutic compositions deliver a therapeutic amount of methylphenidate in a delayed and extended release formulation. The dosage form exhibits a lag time prior to release of from 6 to 8 hours or longer, followed by a sustained release period.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: January 22, 2019
    Assignee: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
    Inventors: David Lickrish, Feng Zhang
  • Patent number: 10182584
    Abstract: Proposed are preparations, comprising special amides and menthol or menthol compounds or aromatic substances, characterized in that they have improved flavor and scent properties, and also that they allow the production of preparations, particularly emulsions with improved shelf life.
    Type: Grant
    Filed: December 12, 2012
    Date of Patent: January 22, 2019
    Assignee: Symrise AG
    Inventors: Torsten Kulke, Sven Siegel, Michael Backes, Benoit Join, Hubert Loges, Günter Kindel
  • Patent number: 10179108
    Abstract: Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) and other CNS stimulant responsive conditions include dosage forms that deliver a therapeutic amount of active drug in a delayed and controlled release formulation. The dosage form can be administered at night and drug release is delayed for from 5 to 8 hours or longer, followed by an extended release.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: January 15, 2019
    Assignee: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
    Inventors: David Lickrish, Feng Zhang
  • Patent number: 10172786
    Abstract: This application discloses oral care compositions comprising cannabinoids, preferably cannabidiol and/or cannabigerol. The oral care composition disclosed in this application may be a tooth paste, a tooth powder, or a mouthwash solution. The oral care composition may be used to treat oral infectious disease, including periimplantitis, periodontitis, oral mucositis, and dental pain.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: January 8, 2019
    Assignee: Axim Biotechnologies, Inc.
    Inventors: George Anastassov, Lekhram Changoer
  • Patent number: 10166219
    Abstract: Formulations and methods of manufacturing formulations for use in colonic evacuation are disclosed herein, in an embodiment, a solid dosage formulation includes an intra-granular fraction intermingled with an extra-granular fraction, wherein the intra-granular fraction includes granules comprising at least one osmotic evacuant agent, at least one antacid, and a first pharmaceutically acceptable excipient component, and wherein the extra-granular fraction includes one or more organic acids, a non-metallic lubricating element, and a second pharmaceutically acceptable excipient component.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: January 1, 2019
    Assignee: Redhill Bipharma Ltd.
    Inventors: Reza Fathi, Patrick Laughlin McLean